nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—Sulpiride—Glyburide—type 2 diabetes mellitus	0.542	1	CrCrCtD
Remoxipride—DRD4—Bromocriptine—type 2 diabetes mellitus	0.112	0.291	CbGbCtD
Remoxipride—DRD3—Bromocriptine—type 2 diabetes mellitus	0.083	0.217	CbGbCtD
Remoxipride—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0528	0.138	CbGbCtD
Remoxipride—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0486	0.127	CbGbCtD
Remoxipride—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0255	0.0667	CbGbCtD
Remoxipride—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0236	0.0615	CbGbCtD
Remoxipride—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0194	0.0505	CbGbCtD
Remoxipride—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0186	0.0484	CbGbCtD
Remoxipride—HTR2A—arteriole—type 2 diabetes mellitus	0.00395	0.187	CbGeAlD
Remoxipride—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00252	0.119	CbGeAlD
Remoxipride—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00169	0.08	CbGeAlD
Remoxipride—HTR2A—hindlimb—type 2 diabetes mellitus	0.00157	0.074	CbGeAlD
Remoxipride—DRD2—nerve—type 2 diabetes mellitus	0.00144	0.0682	CbGeAlD
Remoxipride—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00122	0.0577	CbGeAlD
Remoxipride—HTR2A—artery—type 2 diabetes mellitus	0.00096	0.0453	CbGeAlD
Remoxipride—HTR2A—nerve—type 2 diabetes mellitus	0.000952	0.045	CbGeAlD
Remoxipride—SIGMAR1—islet of Langerhans—type 2 diabetes mellitus	0.000866	0.0409	CbGeAlD
Remoxipride—HTR2A—endothelium—type 2 diabetes mellitus	0.000811	0.0383	CbGeAlD
Remoxipride—SIGMAR1—nephron tubule—type 2 diabetes mellitus	0.000697	0.0329	CbGeAlD
Remoxipride—SIGMAR1—pancreas—type 2 diabetes mellitus	0.000609	0.0287	CbGeAlD
Remoxipride—DRD2—retina—type 2 diabetes mellitus	0.000598	0.0282	CbGeAlD
Remoxipride—SIGMAR1—cortex of kidney—type 2 diabetes mellitus	0.000597	0.0282	CbGeAlD
Remoxipride—SIGMAR1—adipose tissue—type 2 diabetes mellitus	0.000552	0.0261	CbGeAlD
Remoxipride—HTR2A—retina—type 2 diabetes mellitus	0.000394	0.0186	CbGeAlD
Remoxipride—SIGMAR1—liver—type 2 diabetes mellitus	0.000387	0.0183	CbGeAlD
Remoxipride—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000334	0.0158	CbGeAlD
Remoxipride—HTR2A—kidney—type 2 diabetes mellitus	0.000326	0.0154	CbGeAlD
Remoxipride—CYP2D6—kidney—type 2 diabetes mellitus	0.000297	0.014	CbGeAlD
Remoxipride—HTR2A—liver—type 2 diabetes mellitus	0.000206	0.00974	CbGeAlD
Remoxipride—CYP2D6—liver—type 2 diabetes mellitus	0.000188	0.00888	CbGeAlD
Remoxipride—DRD3—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.94e-06	0.000185	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.9e-06	0.000185	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AGT—type 2 diabetes mellitus	9.87e-06	0.000184	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.86e-06	0.000184	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.86e-06	0.000184	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AVP—type 2 diabetes mellitus	9.81e-06	0.000183	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.81e-06	0.000183	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.76e-06	0.000182	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	9.74e-06	0.000182	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.72e-06	0.000181	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	9.7e-06	0.000181	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CYBA—type 2 diabetes mellitus	9.7e-06	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.69e-06	0.000181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.65e-06	0.00018	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.65e-06	0.00018	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.62e-06	0.00018	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	9.56e-06	0.000178	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	9.55e-06	0.000178	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	9.53e-06	0.000178	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.53e-06	0.000178	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PLAT—type 2 diabetes mellitus	9.5e-06	0.000177	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GHRL—type 2 diabetes mellitus	9.5e-06	0.000177	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOB—type 2 diabetes mellitus	9.48e-06	0.000177	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.44e-06	0.000176	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR5—type 2 diabetes mellitus	9.39e-06	0.000175	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CALCA—type 2 diabetes mellitus	9.38e-06	0.000175	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.33e-06	0.000174	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.27e-06	0.000173	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—C3—type 2 diabetes mellitus	9.17e-06	0.000171	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	9.12e-06	0.00017	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LPL—type 2 diabetes mellitus	9.05e-06	0.000169	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.98e-06	0.000167	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.94e-06	0.000167	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	8.88e-06	0.000166	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.86e-06	0.000165	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	8.83e-06	0.000165	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	8.83e-06	0.000165	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.83e-06	0.000165	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	8.79e-06	0.000164	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.75e-06	0.000163	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.73e-06	0.000163	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AGT—type 2 diabetes mellitus	8.72e-06	0.000163	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GCG—type 2 diabetes mellitus	8.68e-06	0.000162	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	8.68e-06	0.000162	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.68e-06	0.000162	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.66e-06	0.000161	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CALM1—type 2 diabetes mellitus	8.57e-06	0.00016	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	8.54e-06	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—LEP—type 2 diabetes mellitus	8.54e-06	0.000159	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOE—type 2 diabetes mellitus	8.54e-06	0.000159	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	8.52e-06	0.000159	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.49e-06	0.000158	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—APOA1—type 2 diabetes mellitus	8.44e-06	0.000158	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.34e-06	0.000156	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	8.29e-06	0.000155	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.26e-06	0.000154	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—C3—type 2 diabetes mellitus	8.15e-06	0.000152	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	8.13e-06	0.000152	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	8.12e-06	0.000152	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	8.12e-06	0.000152	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	8.11e-06	0.000151	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	8.11e-06	0.000151	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.05e-06	0.00015	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.98e-06	0.000149	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.98e-06	0.000149	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	7.97e-06	0.000149	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	7.92e-06	0.000148	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	7.92e-06	0.000148	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	7.92e-06	0.000148	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	7.87e-06	0.000147	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.77e-06	0.000145	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.75e-06	0.000145	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AGT—type 2 diabetes mellitus	7.74e-06	0.000144	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	7.73e-06	0.000144	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.68e-06	0.000143	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	7.64e-06	0.000143	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.62e-06	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.61e-06	0.000142	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.61e-06	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOE—type 2 diabetes mellitus	7.59e-06	0.000142	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—LEP—type 2 diabetes mellitus	7.59e-06	0.000142	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	7.55e-06	0.000141	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.5e-06	0.00014	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	7.5e-06	0.00014	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.5e-06	0.00014	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—GNB3—type 2 diabetes mellitus	7.48e-06	0.00014	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.47e-06	0.000139	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.44e-06	0.000139	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP3—type 2 diabetes mellitus	7.38e-06	0.000138	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AVP—type 2 diabetes mellitus	7.38e-06	0.000138	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.36e-06	0.000137	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF2—type 2 diabetes mellitus	7.35e-06	0.000137	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	7.32e-06	0.000137	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—INS—type 2 diabetes mellitus	7.3e-06	0.000136	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	7.25e-06	0.000135	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	7.24e-06	0.000135	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.22e-06	0.000135	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.18e-06	0.000134	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.15e-06	0.000133	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.14e-06	0.000133	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOB—type 2 diabetes mellitus	7.14e-06	0.000133	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	7.11e-06	0.000133	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	7.1e-06	0.000132	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	7.1e-06	0.000132	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	7.1e-06	0.000132	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.06e-06	0.000132	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.05e-06	0.000132	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.02e-06	0.000131	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.02e-06	0.000131	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	6.97e-06	0.00013	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.93e-06	0.000129	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	6.91e-06	0.000129	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LPL—type 2 diabetes mellitus	6.81e-06	0.000127	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.78e-06	0.000126	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.77e-06	0.000126	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	6.76e-06	0.000126	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.7e-06	0.000125	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.67e-06	0.000124	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.5e-06	0.000121	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	6.49e-06	0.000121	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—INS—type 2 diabetes mellitus	6.48e-06	0.000121	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	6.42e-06	0.00012	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	6.42e-06	0.00012	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.4e-06	0.000119	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.4e-06	0.000119	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	6.39e-06	0.000119	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.38e-06	0.000119	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.38e-06	0.000119	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.28e-06	0.000117	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.27e-06	0.000117	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.26e-06	0.000117	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	6.26e-06	0.000117	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.24e-06	0.000116	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	6.24e-06	0.000116	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	6.16e-06	0.000115	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	6.16e-06	0.000115	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—C3—type 2 diabetes mellitus	6.14e-06	0.000114	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—RELA—type 2 diabetes mellitus	6.02e-06	0.000112	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.95e-06	0.000111	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.95e-06	0.000111	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.93e-06	0.000111	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.92e-06	0.000111	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.85e-06	0.000109	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.84e-06	0.000109	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.83e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.83e-06	0.000109	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.81e-06	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.81e-06	0.000108	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.74e-06	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.73e-06	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	5.71e-06	0.000107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	5.71e-06	0.000107	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.68e-06	0.000106	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.68e-06	0.000106	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.65e-06	0.000105	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.48e-06	0.000102	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.47e-06	0.000102	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.43e-06	0.000101	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.4e-06	0.000101	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.39e-06	0.000101	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.35e-06	9.98e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	5.31e-06	9.9e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.31e-06	9.9e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	5.28e-06	9.86e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.21e-06	9.72e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.18e-06	9.66e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.13e-06	9.58e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.1e-06	9.51e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.08e-06	9.48e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.06e-06	9.44e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.98e-06	9.29e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	4.96e-06	9.25e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	4.92e-06	9.18e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	4.88e-06	9.1e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.88e-06	9.1e-05	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.87e-06	9.09e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	4.83e-06	9.01e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.83e-06	9e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.8e-06	8.96e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.8e-06	8.95e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.79e-06	8.94e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.79e-06	8.94e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.77e-06	8.91e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—SRC—type 2 diabetes mellitus	4.73e-06	8.83e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	4.73e-06	8.82e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.72e-06	8.81e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.72e-06	8.8e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	4.71e-06	8.79e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.7e-06	8.76e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.61e-06	8.6e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	4.59e-06	8.56e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.56e-06	8.51e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.56e-06	8.5e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	4.53e-06	8.46e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.51e-06	8.42e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.48e-06	8.36e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.42e-06	8.25e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.35e-06	8.12e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.35e-06	8.11e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.35e-06	8.11e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.28e-06	7.98e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.28e-06	7.98e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.27e-06	7.96e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.23e-06	7.89e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.2e-06	7.84e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.15e-06	7.74e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.13e-06	7.71e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.09e-06	7.64e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.09e-06	7.64e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.06e-06	7.58e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.05e-06	7.56e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	4.03e-06	7.52e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4e-06	7.47e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.76e-06	7.01e-05	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.73e-06	6.95e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.69e-06	6.89e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.68e-06	6.88e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.67e-06	6.84e-05	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.67e-06	6.84e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.63e-06	6.78e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.61e-06	6.73e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	3.53e-06	6.58e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.49e-06	6.51e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.46e-06	6.45e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.45e-06	6.44e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.43e-06	6.41e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.4e-06	6.34e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.38e-06	6.31e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.33e-06	6.21e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.22e-06	6e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-06	5.95e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.17e-06	5.92e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	3.17e-06	5.91e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.13e-06	5.85e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.08e-06	5.75e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.03e-06	5.66e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.03e-06	5.66e-05	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.94e-06	5.49e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.88e-06	5.37e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.83e-06	5.28e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.83e-06	5.28e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.82e-06	5.26e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.77e-06	5.18e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.77e-06	5.18e-05	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.61e-06	4.87e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.17e-06	4.04e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.13e-06	3.98e-05	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2e-06	3.73e-05	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.97e-06	3.67e-05	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-06	2.6e-05	CbGpPWpGaD
